The Swiss Market Index (SMI) traded in negative territory on Tuesday, weighed down by broad pressure on cyclical equities. Losses across cyclical sectors dragged the benchmark index lower during the session.
Meanwhile, defensive heavyweight shares including pharmaceutical giants Roche and Novartis helped cushion the market against steeper declines, providing a floor for the index amidst the broader downturn.
